A rare case of disseminated amebiasis in a patient on biologic therapy for chronic rhinosinusitis
International Forum of Allergy & Rhinology · 2025
DOI: 10.1002/alr.23473 ↗Kurz gefasst
Fallbericht in der Zeitschrift International Forum of Allergy & Rhinology, 2025. Verfasst von Ariel Omiunu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Otolaryngology-Head and Neck Surgery, Department of Surgery, Yale School of Medicine, New Haven, Connecticut, USA. Hauptthemen laut MEDLINE: Sinusitis, Rhinitis, Antibodies, Monoclonal, Humanized. Die Arbeit nennt 10 Literaturangaben.
Abstract (Originalsprache)
Key points Dupilumab targets Th2‐associated inflammatory mediators to reduce disease burden in CRSwNP. While rare, potential sequelae include viral, helminth, and potentially amebic infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Otolaryngology-Head and Neck Surgery, Department of Surgery, Yale School of Medicine, New Haven, Connecticut, USA.
ORCID-Profile: Ariel Omiunu
Zitieren
APA
Omiunu, A., Brown, L., Kayastha, D., & Manes, R. P. (2025). A rare case of disseminated amebiasis in a patient on biologic therapy for chronic rhinosinusitis. International Forum of Allergy & Rhinology. https://doi.org/10.1002/alr.23473
Vancouver
Omiunu A, Brown L, Kayastha D, Manes RP. A rare case of disseminated amebiasis in a patient on biologic therapy for chronic rhinosinusitis. International Forum of Allergy & Rhinology. 2025. doi:10.1002/alr.23473
BibTeX
@article{Omiunu2025,
author = {Omiunu, Ariel and Brown, Lindsey and Kayastha, Darpan and Manes, R Peter},
title = {A rare case of disseminated amebiasis in a patient on biologic therapy for chronic rhinosinusitis},
journal = {International Forum of Allergy & Rhinology},
year = {2025},
doi = {10.1002/alr.23473}
}
EUVIMED